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1  | INTRODUC TION
Corneal blindness is the second most common eye disorder and 
represents a significant clinical problem with many cases of unilat‐
eral blindness annually reported and the available cornea for trans‐
plantation does not satisfy the surgical demand.1 Moreover, several 
inflammation and stress conditions delay wound healing, leading 
to epithelial defects and affecting transplant procedure success. 
Starting from invaluable knowledge about function and regulation of 
limbal epithelial stem cells, scientists hardly work on both cell ther‐
apy and drug therapy to overcome the lack of donor tissues.
To identify new therapeutic targets for improving the regen‐
erative capability of resident or transplanted stem cells, it is im‐
portant to elucidate about the molecular factors (the stem triad, 
including oct4, sox2 and nanog) and cytoskeleton‐remodelling 
proteins involved in the regulation of stemness or differentiation 
decision.2‐4 Several studies have shown that corneal epithelial cell 
migration involves the integrin‐β1 pathway. By contact with extra 
 
Received: 7 March 2019  |  Revised: 26 April 2019  |  Accepted: 15 May 2019
DOI: 10.1111/jcmm.14438  
O R I G I N A L  A R T I C L E
PFN1 and integrin‐β1/mTOR axis involvement in cornea 
differentiation of fibroblast limbal stem cells
Laura Tomasello1  |   Antonina Coppola1 |   Maria Pitrone1 |   Valentina Failla2 |   
Salvatore Cillino2 |   Giuseppe Pizzolanti1 |   Carla Giordano1
This is an open access article under the terms of the Creat ive Commo ns Attri bution License, which permits use, distribution and reproduction in any medium, 
provided the original work is properly cited.
© 2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
1Laboratory of Regenerative Medicine 
“Aldo Galluzzo”, Section of Endocrinology, 
Diabetology and Metabolism, Department 
of Promozione della Salute, Materno‐
Infantile, di Medicina Interna e Specialistica 
di Eccellenza “G. D’Alessandro” 
(ProMISE), University of Palermo, Palermo, 
Italy
2Department of Ophthalmology, University 
of Palermo, Palermo, Italy
Correspondence
Carla Giordano, Chief of Section of 
Endocrinology, ProMISE, University of 
Palermo, Piazza delle Cliniche 2, 90127 
Palermo, Italy.
Email: carla.giordano@unipa.it




Ex vivo limbal stem cell transplantation is the main therapeutic approach to address 
a complete and functional re‐epithelialization in corneal blindness, the second most 
common eye disorder. Although important key points were defined, the molecular 
mechanisms involved in the epithelial phenotype determination are unclear. Our 
previous studies have demonstrated the pluripotency and immune‐modulatory of 
fibroblast limbal stem cells (f‐LSCs), isolated from the corneal limbus. We defined a 
proteomic profile especially enriched in wound healing and cytoskeleton‐remodel‐
ling proteins, including Profilin‐1 (PFN1). In this study we postulate that pfn‐1 knock 
down promotes epithelial lineage by inhibiting the integrin‐β1(CD29)/mTOR pathway 
and subsequent NANOG down‐expression. We showed that it is possible modulate 
pfn1 expression levels by treating f‐LSCs with Resveratrol (RSV), a natural compound: 
pfn1 decline is accompanied with up‐regulation of the specific differentiation epithe‐
lial genes pax6 (paired‐box 6), sox17 (sex determining region Y‐box 17) and ΔNp63‐α 
(p63 splice variant), consistent with drop‐down of the principle stem gene levels. 
These results contribute to understand the molecular biology of corneal epithelium 
development and suggest that pfn1 is a potential molecular target for the treatment 
of corneal blindness based on epithelial cell dysfunction.
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cellular matrix (ECM) components, integrin‐β1 transmits signals 
to influence cell shape, cell proliferation and adhesion, principally 
modulating the intracellular actin binding‐proteins, including profi‐
lin‐1 (PFN1).5‐8 A controversial bio‐pathological role was assessed 
in cancer for PFN1: in breast, pancreas and liver carcinomas it was 
found down‐expressed, whereas over‐expressed in gastric can‐
cer, in which probably it inhibited proliferation and migration.9‐12 
In human corneal epithelial regeneration and wound closure in‐
volve all limbal stem cell (LSC) populations, among which limbal 
epithelial stem cells (LESCs) and fibroblast‐like limbal stem cells 
(f‐LSCs), both hosted in the limbus.13‐17 A conventional therapy to 
restore the limbal niche consists in transplanting ex vivo expanded 
LESCs.18‐20 However, this strategy is tainted by several disadvan‐
tages such as cell‐passage number limit, allograft rejection risk, 
the xeno‐feeder proteins and cell contaminations.21‐23 For these 
reasons, laboratory scientists perpetually evaluated novel isola‐
tion and maintenance protocols to improve ex vivo expansion of 
LSCs. In vitro and in vivo experiments have provided evidence 
about the biological effects of some natural plant polyphenols, 
therefore proposed as complement treatment in ocular diseases. 
In particular, resveratrol (RSV), a grape stilbenoid, revealed a mod‐
est beneficial impact on numerous cellular pathways implicated 
in age‐related ocular disorders, such as oxidative stress, inflam‐
mation, mitochondrial dysfunction, apoptosis and survival.24‐26 
Recent studies have demonstrated that RSV acts in a dose‐ and 
time‐dependent manner on MSCs, including human primary kera‐
tinocytes.27‐29 In the last few years, our group has focused on the 
pluripotent and immune‐modulator characteristics in f‐LSCs de‐
fined by a proteomic profile especially enriched with remodelling 
and wound healing proteins, including pfn1 and integrin‐ 1β.30‐32 In 
the present study, we speculate the existence of a pfn1/integrin‐
β1 nanog axis that regulates the stemness/differentiation equilib‐
rium acting with nanog. Moreover, we show RSV treatment being 
a possible natural drug to modulate this mechanism. Furthermore, 
we postulate the possibility to obtain epithelial progenitor‐like by 
f‐LSCs in vitro. Taking together, these results suggest pfn1 as a 
potential molecular target for the treatment of corneal blindness 
based on epithelial cell dysfunction.
2  | MATERIAL S AND METHODS
2.1 | Limbus isolation
The study was approved by the Ethics Committee of the AOUP, 
University of Palermo (No. 09/2009). The informed written 
consent was obtained by each patient and human tissues were 
used in accordance with the Declaration of Helsinki. The nor‐
mal human cornea‐scleral rings from five donors were obtained 
2‐3 hours post‐surgery from the Ophthalmology Department 
(AOUP, University of Palermo). The rings were kept in Hank's 
Balanced Salt Solution (HBSS, PAA, Pashing, Austria) and then 
cut into small segments to facilitate separation of the limbus from 
the sclera.
2.2 | Establishment of limbal cell cultures
Human fibroblast mesenchymal stem cells (f‐LSCs) were isolated 
and cultured as previously described.31 Briefly, the limbal segments 
were incubated with collagenase I overnight, the day after the di‐
gest was placed in a dish culture and maintained in DMEM/F12 sup‐
plemented with 5% embryonic stem cell‐tested Fetal Bovine Serum 
(EC‐FBS, PAA, Pashing, Austria), 1X ITS (5 µg/mL Insulin, 5 µg/mL 
Transferrin, 5 µg/mL Selenium, PAA, Pashing, Austria) and 20 ng/
mL basic Fibroblast Growth Factor (b‐FGF, Preprotech, London, UK). 
Subsequently, the f‐LSCs and LESCs were selected by trypsinization 
and f‐LSCs subcultures were set up.
2.3 | Small interfering RNA (siRNA) preparation and 
cell transfection
Oct4, sox‐2, nanog and profilin‐1 were silenced using appropriate 
duplex siRNA (the product information and incubation time were re‐
ported in Supporting Information 1 (Table 1). The f‐LSC cell transfec‐
tions were carried out with INTERFERin transfection agent (Polyplus 
Transfection), according to the manufacturer's instructions. Briefly, 
cells were seeded into six‐well plates at a density of 2 × 104 cells/
well. The transfection agent and siRNA complex were added to the 
cells and incubated for 72 hours. Each assay was performed in dupli‐
cate at least three independent experiments.
2.4 | Cell viability
Cell viability was evaluated by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐
diphenyltetrazolium bromide (MTT) assay, according to manufac‐
turer's protocol. Briefly, f‐LSCs were grown in 96‐well plates at 
a density of 2 × 104 cells/cm2 and cell viability was evaluated at 
24, 48 and 72 hours. The absorbance at 550 nm was determined 
using MultisKan FC microplate reader (Thermo Fisher Scientific, 
UK).33
2.5 | RNA extraction, quantification and  
reverse‐transcription
f‐LSC total RNA was extracted and purified using Rneasy Mini 
Kit (Qiagen, Milan, Italy) according to the manufacturer's instruc‐
tions. For quantitative and qualitative analysis Nano Drop 2000 
(Thermo Scientific) was used. Total RNA were reverse‐transcribed 
to cDNA using Reverse Transcriptase Rnase kit (Improm II, Promega, 
Wisconsin, USA).
2.6 | Real‐time quantitative PCR (qRT‐PCR)
qRT‐PCR primers were purchased from Qiagen (QuantiTect® Primer 
Assays, Qiagen, Milan, Italy) and Eurofin MWG (Biotech, Germany) and 
are listed in Supporting Information 1 (Table 2). All reactions were per‐
formed using the Quantitect SYBR Green PCR Kit (Qiagen, California, 
USA) on the RotorGene Q Instrument (Qiagen, California, USA). Each 
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cDNA sample was mixed with specific primer sets and PCR master mix 
and amplification were performed as previously described.31 Briefly, 
amplification conditions were the following: 95° for 3 minutes, 40 cy‐
cles at 95°C for 20 seconds, 60°C for 30 seconds and 72°C for 60 sec‐
onds. Each reaction was performed at least in triplicate. The melting 
peak analysis determined the specificity of the amplified products. 
The quantification was performed normalising expression levels to β‐
actin‐mRNA levels (used as the housekeeping gene) and comparing to 
the expression levels of an f‐LSC pool (used as the internal control). 
The relative gene expression levels were expressed as fold change ac‐
cording to the 2−ΔΔCt method.34 The results were represented as histo‐
grams on GraphPad Software, Inc, California.
2.7 | Immunofluorescence staining
The f‐LSC cells were seeded into six‐well plates at a density of 
2 × 104 cells/well and the staining was performed as previously 
described.31 Briefly: 1) for cell surface markers the cells were, pre‐
viously, kept in blocking solution (calcium‐ and magnesium‐free 
PBS plus FBS10%) for 45 minutes incubated with primary antibody 
for 30 minutes, and fixed with 2% paraformaldehyde (PFA) for 
15 minutes at 4°C; 2) for intracellular cell markers the cells were 
firstly fixed with 2% PFA for 15 minutes at 4°C, permeabilised with 
blocking solution added with saponin for 20 minutes and finally 
stained with primary antibody. The antibody dilution, incubation 
and detection conditions are shown in Supporting Information 1 
(Table 3). Unstained cells were used as a negative control.
2.8 | Flow cytometry analysis
Cell marker staining was performed using BD Cytofix/Cytoperm™ 
Plus Fixation/Permeabilization Kit (BD Biosciences, Milan, Italy) ac‐
cording to the manufacturer's instructions. Briefly, 100 µL of cell 
suspension containing 5 × 105 cells was used for each flow cyto‐
metric reaction. The antibody dilution, incubation and detection 
conditions are shown in Supporting Information 1 (Table 3). All sam‐
ples were acquired with a FACS Calibur flow cytometer (Becton‐
Dickinson, New Jersey, USA) and analysed with the CellQuest Pro 
software.
2.9 | Network analysis and GO analyses
Network analysis was performed on the modulated genes coding for 
the invariant and variant proteins using the STRING (Search Tool for 
the Retrieval of Interacting Genes/Proteins) website (http://string‐
db.org/).35
2.10 | Limbal epithelial differentiation
Complete epithelial differentiation medium (EDM) was prepared 
according to a previously validated composition: low‐glucose 
Dulbecco's modified Eagle's medium (DMEM) 75% and Ham's F12 
medium 25% (both Gibco, UK). This medium was supplemented with 
the following: foetal bovine serum 10%, hydrocortisone 0.4 µg/
mL (PAA Laboratories, Inc, UK) insulin 5 µg/mL (Actrapid®, Novo 
Nordisk, Denmark), triiodothyronine 1.4 ng/mL (Sigma‐Aldrich, 
UK), adenine 24 µg/mL (Sigma‐Aldrich, UK), Isoprenaline 4 µg/mL 
(Sigma‐Aldrich, UK) and EGF 10 ng/mL (PeproTech, Inc, UK).36 After 
15 days of cultivation in EDM, the differentiation potential was eval‐
uated by qRT‐PCR for CK3 and CK12 the two corneal epithelium‐
specific keratins.37
2.11 | Preparation of resveratrol and 
experimental design
Powder of RSV was dissolved in DMSO as a stock solution at a 
concentration of 100 mmol/L, and stored at −20°C. The RSV di‐
lution was prepared in a serum‐containing medium at different 
concentrations (10 μM, 20 μM and 50 μM). Each test was inde‐
pendently run three times with the untreated cells as the con‐
trol. Cytotoxicity assay: the f‐LSCs with or without 10 μM, 20 μM 
and 50 μM of RSV were seeded in a 96‐well plate at a density of 
2 × 104 cells/cm2 and cultured up to 72 hours. Cell viability was 
evaluated by MTT assay.
2.12 | Protein extraction and Western blot assay
Silenced and un‐silenced f‐LSCs were scraped and incubated in ice 
for 30 minutes with RIPA buffer (50 mM Tris‐HCl, pH 7.4, 150 mM 
NaCl, 1% Nonidet P40) and protease inhibitor cocktail (Roche). Total 
cellular lysate was centrifuged at 14,000 rpm for 1 hour to clear 
cell debris and the supernatant was stored at −80°C until analysis. 
Protein concentration in the cellular extracts was determined using 
Bradford assay. Proteins were denatured in Laemmli sample buffer 
(2% SDS, 10% glycerol, 5% 2‐mercaptoethanol, 62.5 mM Tris‐HCl pH 
6.8, 0.004% bromophenol blue), separated on 12% polyacrylamide 
gels, transferred to nitrocellulose membranes (TransBlot Transfer 
Medium Biorad), and blotted with the primary antibodies listed in 
Supporting Information 1 (Table 3). Antigen‐antibody complexes 
were visualised using SuperSignal West Femto Maximum Sensitivity 
Substrate (Pierce) on a CCD camera (Chemidoc, Biorad). Western 
blot bands were quantified by densitometry using ImageJ soft‐
ware and the results were represented as histograms on GraphPad 
Software, Inc, California.
2.13 | Pathway representation
The pathway proposed was represented as a graph on SmartDraw 
Software, LLC (https ://www.smart draw.com/).
2.14 | Statistical analysis
All assays were performed in triplicate. The data were reported as 
means (± standard deviation, SD) and compared using the appropri‐
ate version of Student's t test. P values < 0.05 were considered sta‐
tistically significant (P < 0.05).
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3  | RESULTS
3.1 | Nanog is the key regulator of stem cell 
molecular profile in f‐LSCs
We previously identified a stem proteomic f‐LSC profile (SPP) by 
two‐dimensional gel electrophoresis (2D‐IPG) including some wound 
healing proteins, that is profilin‐1, cofilin, vinculin and grp78, lectin‐1 
and thioredoxin‐1 (txn1) (Supporting Information 2, Figure 1). To elu‐
cidate the association among the stem transcriptional triad and the 
stem proteomic f‐LSC profile, several gene‐silencing experiments 
were performed. The f‐LSCs were incubated with oct‐4, sox2 and 
nanog siRNA individually up to 72 hours, and finally the mRNA lev‐
els of gene coding for the SPP were evaluated (Figure 1A). Relative 
expression analysis revealed a significant modification in the fold 
change (FC) values for all stem gene markers (Supporting Information 
2, Table 4). In particular, in siRNA‐transfected f‐LSCs significant re‐
duction in the mRNA levels of profilin‐1 and cofilin‐1 was detected, 
together with an appropriate elevation of vinculin mRNA levels, 
when compared to the control f‐LSCs. In detail, profilin‐1 mRNA lev‐
els were decreased up to 0.49 ± 0.09, 0.29 ± 0.07 and 0.06 ± 0.012 
FC in oct4, sox2 and nanog siRNA‐transfected f‐LSCs, respectively 
(P < 0.001) when compared to the no‐target siRNA f‐LSCs.
To understand if a hierarchy exists behind the regulation of the 
stem transcriptional triad, we observed the behaviour of all three 
genes after silencing each of them up to 72 hours. The efficiency 
for gene silencing experiments of oct4, sox2, nanog was 91.51%, 
88,72% and 83.32% respectively (represented in Figure 1B,C by # 
sign). In oct4 siRNA‐transfected f‐LSCs, we found over‐expression 
F I G U R E  1   Stem profile after stem transcription factor silencing. A, qRT‐PCR shows the profilin‐1, cofilin, vinculin, lectin‐1, grp78 and 
thioredoxin‐1 (txn‐1) mRNA levels in oct4, sox2 or nanog siRNA‐transfected f‐LSCs at 72 h vs the no‐target siRNA‐transfected f‐LSCs. B, 
qRT‐PCR shows the modulation of oct4 mRNA levels in sox2‐ or nanog‐siRNA transfected f‐LSCs vs the control f‐LSCs. C, qRT‐PCR shows 
the modulation in mRNA level of sox2 in oct4 or nanog‐siRNA transfected f‐LSCs vs the control f‐LSCs. D, qRT‐PCR shows the modulation 
of nanog mRNA levels in oct4 or sox2‐siRNA transfected f‐LSCs vs the control f‐LSCs. siRNA no‐target f‐LSCs were used as negative 
controls for all gene silencing experiments. In B, C and D the histogram bars labelled with # represent si‐RNA target gene. The fold change 
was calculated with the Delta Delta Ct method using the Rotor Gene Q software and the expression was normalised for the housekeeping 
gene β‐actin. The histogram graphs were performed by GraphPad Software, Inc, California and are represented as ± SD with *P < 0.05, 
**P < 0.02, ***P < 0.001, ns= no significant, SD = Standard deviation; P = P value, FC = fold change. All pictures are representative of three 
independent experiments
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of sox2 mRNA levels compared to the control f‐LSCs (up to 
2.15 ± 0.86 fc, P < 0.001) (Figure 1B), whereas in sox2 siRNA‐trans‐
fected f‐LSCs higher oct4 mRNA levels were detected (2.52 ± 0.75 
fc, P < 0.02) (Figure 1C). It is noteworthy that in nanog siRNA‐
transfected f‐LSCs, both oct4 and sox2 mRNA levels were over‐
expressed, as is demonstrated by the up‐regulation of 2.37 ± 0.54 
FC (P < 0.001) in oct4 mRNA levels and 9.45 ± 1.21 FC in sox2 
mRNA levels (P < 0.001) respect to the control f‐LSCs (Figure 1B,C). 
Equally in oct4 and sox2 siRNA‐transfected f‐LSCs the nanog 
mRNA levels were decreased when compared to the control f‐LSCs 
(0.40 ± 0.08 and 0.58 ± 0.13 FC, P < 0.02, respectively) (Figure 1D). 
These results suggest, first of all, that sox2 expression was main‐
tained at a higher level in each experimental condition, and sec‐
ondly that a compensatory mechanism probably exists for oct4 
and sox2 expression and finally that oct4 and sox2 expression is 
similarly regulated through a possible negative feedback which is 
nanog‐dependent.
3.2 | Nanog silencing affects cell cycle 
promotion and increases expression of important 
differentiation markers in f‐LSCs
The cell cycle analysis was performed by flow cytometry to define if 
nanog silencing alone negatively affects the cell cycle progression. 
The f‐LSCs were incubated with nanog‐siRNA up to 72 hours: after 
silencing, a reduced number of cells in S‐ and G2‐phase and an in‐
creased one in G0/G1‐phase indicated cell cycle arrest (Supporting 
Information 2, Figure 2). The proliferation index (PI) was estimated 
at 7.69 ± 2.15% and 29.81 ± 4.57% (P < 0.02), in nanog siRNA‐trans‐
fected f‐LSCs and in the control f‐LSCs, respectively (Figure 2A). 
Moreover, we evaluated the principal genes involved in cell prolif‐
eration and apoptosis regulation, by qPCR analysis: c‐kit (also SCFR, 
Stem cell factor Receptor), ccnd1 (cyclin‐D1) and cdkn1b (cyclin‐de‐
pendent kinase inhibitor 1B) and bax (Bcl‐2‐associated X protein, pro‐
apoptotic gene) and bcl‐2 (B‐cell lymphoma 2, anti‐apoptotic gene). 
A significant down‐expression in ccnd1 mRNA levels was detected 
(0.75 ± 0.13 FC, P < 0.02), whereas no differences in c‐kit and bcl‐2 
mRNA levels (P > 0.05) were found. Interestingly, significant hyper‐
expression of cdkn1b and bax mRNA levels (4.66 ± 0.15 FC, and 
2.11 ± 0.53 FC, P < 0.001, respectively) in nanog siRNA‐transfected f‐
LSCs was found, when compared to the control f‐LSCs (Figure 2B). In 
light of this, we investigated the presence of epithelial lineage genes: 
in nanog siRNA‐transfected f‐LSCs mRNA expression levels of pax6 
(paired‐box 6) and sox17 (sex determining region Y‐box 17) showed 
no significant differences compared to LESCs (the positive control). 
By contrast, significant down‐expression of integrin‐1β (CD29) com‐
pared to the control f‐LSCs, was detected (Figure 2C). However, no 
change in cellular morphology at 72 hours was observed (Figure 2D). 
Therefore, we concluded that a decreased expression of nanog is ac‐
companied by induction of f‐LSCs towards epithelial lineage.
F I G U R E  2   Nanog‐dependent lineage commitment in f‐LSCs. A, The bar plot represents the comparative cell cycle distribution analysis 
between nanog‐siRNA transfected f‐LSCs and f‐LSCs at 72 h silencing. B, qPCR analysis of cell cycle regulators and proliferation markers 
cdnk1b, ccnd1, c‐kit, bax and bcl‐2 in nanog‐siRNA transfected f‐LSCs vs the control f‐LSCs, at 72 h silencing. No‐target siRNA f‐LSCs were 
used as a negative control. C, The bar graphs represent the relative mRNA expression of early epithelial progenitor markers, pax6, sox17 and 
ΔNp63α, and limbal stromal mesenchymal, CD29 (intregin‐1β), in nanog‐siRNA transfected f‐LSCs vs the control f‐LSCs, at 72 h silencing. 
LESCs and f‐LSCs were used as positive control of the epithelial progenitor markers and the stromal mesenchymal stem cell markers, 
respectively. The bar graphs were done using GraphPad Software, Inc, California and are represented as ± SD with **P < 0.02, ***P < 0.001, 
ns= no significant, SD = Standard deviation; P = P value, FC = fold change. All pictures are representative of three independent experiments. 
D, Optical microscope images (20x) represent the typical cuboidal cell shape of LESC monolayer subculture (top image), the fibroblast‐like 
shape of f‐LSCs (middle image) and no difference in morphology in nanog‐siRNA transfected f‐LSCs (bottom image) at 72 h. Photos were 
capture by Nikon DS‐fI1
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3.3 | Limbal epithelial commitment and epithelial 
differentiation potential of f‐LSCs
The fresh f‐LSCs were run for flow cytometry analysis of PFN1, 
integrin‐β and NANOG, as mesenchymal stem cell markers, and 
for ΔNp63α (p63 splice variant) and SOX17, as the epithelial com‐
mitment markers. As shown in Figure 3A the f‐LSCs represent a 
higher double stained cell population for PFN1/integrin‐β1 and 
PFN1/NANOG (84.7 ± 6.2% and 83.17 ± 5.75%, respectively) and 
were negative for ΔNp63α and SOX17. Moreover, a protein‐inter‐
action networks (PIN) analysis was performed on https ://string‐
db.org. We involved in the computational exploration the SPP, 
the stem transcriptional triad and the epithelial related proteins. 
A more extended search for interaction highlighted the implica‐
tion of cell cycle gene regulation, that is bax, ccnd1 and cdkn1b 
and of integrin‐1β (Figure 3B). A significant co‐relation was found 
between all proteins included in the investigation (P < 6‐15): ten 
of them were proteins of the response to wounding (red nodes in 
Figure 3B), five proteins were involved in cell fate specification 
(dark violet nodes in Figure 3B), six proteins in regulation of epi‐
thelial cell proliferation (light blue nodes in Figure 3B), eight were 
related to cell activation (light green nodes in Figure 3B), nine 
proteins to epithelium development (yellow nodes in Figure 3B), 
seven proteins to morphogenesis of an epithelium (bright violet 
nodes in Figure 3B), ten to tissue development (dark green nodes 
in Figure 4B) and six were proteins of stem cell differentiation 
(orange nodes in Figure 3B). The significant involved gene ontol‐
ogy (GO) terms are listed for each biological process detected in 
Supporting Information 2 (Table 5). Finally, the f‐LSCs were cul‐
tured in the traditional epithelial differentiation medium (EDM) 
up to 15 days and we subsequently analysed the molecular pro‐
file compared to the control f‐LSCs and LESCs by qPCR analy‐
sis (Figure 3C). An increased expression for all corneal epithelial 
progenitor genes was detected in EDM‐treated f‐LSCs when 
compared to control f‐LSCs (the negative control for epithelial 
markers) and interestingly the mRNA expression levels were 
comparable with the LESC ones (the positive control for epithelial 
markers). Specifically, no significant changes in pax‐6, ΔNp63α, 
CK15 (cytokeratin‐15, specific progenitor epithelial markers) and 
sox17 expression were found (0.65 ± 0.13, 0.44 ± 0.06, 0.51 ± 0.18 
FC vs LESCs, respectively, P > 0.05). EDM incubation induced re‐
markable down‐expression of the MSC genes (0.12 and 0.44 FC, 
P < 0.001, for integrin‐β1 and pfn1 mRNA respectively in EDM‐
treated f‐LSCs vs the control f‐LSCs). Interestingly, pfn1 mRNA 
levels were closely comparable with those of LESCs. To verify the 
mature corneal differentiation capacity of human f‐LSCs, we in‐
vestigated the expression of epithelial corneal cytokeratin, CK3 
and CK12, the two principles corneal lineage markers.37 The qPCR 
analysis was performed on f‐LSCs comparing three different time 
points of differentiation treatment: 48 hours, 7 and 15 days. A 
significant time‐dependent increment of CK3 and CK12 mRNA 
level expression (P < 0.024 and P < 0.017, respectively) in EDM‐
treated f‐LSCs was found (Figure 3D,E).
3.4 | Knock‐down of profilin‐1 inhibits f‐LSC 
proliferation and promotes the epithelial genotype: 
Integrin‐β1, profilin‐1 and nanog a possible 
central node in f‐LSCs regulation of stemness
The computational analysis suggested involvement of pfn1 in cell 
fate; to elucidate this role, pfn1 was knocked down. After 72 hours 
of incubation, pfn1 siRNA‐transfected f‐LSCs showed lower cellular 
density compared to the control f‐LSCs (Figure 4A: i, iv of the immu‐
nofluorescence panel, respectively). Immunofluorescence assays for 
integrin‐β1 and NANOG were assessed (Figure 4A): in pfn1 siRNA‐
transfected f‐LSCs the integrin‐β1 detection was weakly preserved 
vs the control f‐LSCs (Figure 4A.ii vs 4A.v), whereas we detected no 
positive stain for NANOG in pfn1 siRNA‐transfected f‐LSCs vs the 
control f‐LSCs (Figure 4A.viii vs 4A.xi). The lower cellular density eval‐
uated in pfn1 siRNA‐transfected f‐LSCs was investigated by a prolif‐
eration curve analysis: the MTT showed that pfn1 siRNA‐transfection 
significantly inhibited f‐LSC growth when compared to control f‐LSCs 
at 48, 72 and 96 hours (P < 0.05) (Figure 4B). In addition, cell cycle 
was assessed by flow cytometry to determine the mechanism under‐
lying the observed cell growth inhibition (Supporting Information 2, 
Figure 3). We evaluated a lower PI in pfn1 siRNA‐transfected f‐LSCs 
vs the control f‐LSCs (8.75 ± 3.64% vs 26.17 ± 5.12% PI, Figure 4C). 
Given the overlapping trend of the cell cycle progression between 
pfn1 siRNA‐transfected f‐LSCs and the nanog siRNA‐transfected f‐
LSCs, we analysed the mRNA levels of the stem transcriptional triad 
and the epithelial related genes in pfn1 siRNA‐transfected f‐LSCs. 
All f‐LSC stem cell marker expression levels underwent remarkable 
variations, ie we detected significant up‐regulation of oct4 and sox2 
mRNA levels counteracted by a drop in nanog expression when com‐
pared to the control f‐LSCs (Figure 4D, upper panel); by contrast, 
sox17, pax6 and ΔNp63α mRNA were detected (Figure 4D, lower 
panel). Therefore, these results confirm that pfn1 could have an im‐
portant role in promotion of f‐LSCs epithelial commitment.
3.5 | Profilin‐1 acts through mTOR activity
Because of the closer relation revealed between pfn1 and integ‐
rin‐β1 and the closer crosstalk between integrin and mTOR sig‐
nalling, a Western blot analysis to investigate mTOR activity was 
performed (Figure 5A). Protein quantification (Figure 5A, right 
panel) showed that the mTOR activity was down‐regulated up‐to 
62.2% in pfn1 si‐RNA f‐LSCs vs the control f‐LSCs. Moreover, we 
detected a decrease in the NANOG protein level of about 50.8% 
in siRNA‐transfected pfn1 when compared to the control f‐LSCs. 
In Figure 5B we show a graphic representation of the mechanism 
proposed according to our finding. It can be seen that pfn1 and inte‐
grin‐β1 co‐operation mediates the activation of the mTOR pathway 
leading to the transcription of mesenchymal stem genes; whereas 
when pfn1 was down‐regulated the signalling is inhibited, because 
of mTOR phosphorylation failure, NANOG decreases its protein 
levels and switches its partner to SOX17, driving f‐LSCs to epithelial 
differentiation.
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F I G U R E  3   f‐LSC epithelial differentiation potential. A, A representative flow staining of double negative fresh f‐LSCs for ΔNp63α/
SOX17 (upper panel), double positive f‐LSC population for PFN1/CD29, PFN1/NANOG and SOX2+/CD29 (in lower panel), NC = Negative 
Control (Isotype control), CD29 = integrin‐β1. B, The node directed graph represents the protein‐interaction networks analysis that occurs in 
f‐LSCs highlighting the epithelial differentiation potential. C, The bar graphs represent the relative mRNA expression of epithelial progenitor 
markers, pax6, ΔNp63α, CK15, sox17 and limbal stromal mesenchymal, CD29, in differentiated f‐LSCs (f‐LSCs + EDM), no treated f‐LSCs and 
LESCs, (CD29 = integrin‐β1, EDM = epithelial differentiation medium); D, E, The bar graphs represent relative mRNA expression of corneal 
epithelial cytokeratins, CK3 (D) and CK12 at different time points of differentiation process (48 h, 7 and 15 d) (E). The bar graphs were done 
using GraphPad Software, Inc, California and are represented as ± SD with *P < 0.05, ns = no significant, SD = Standard deviation; P = P 
value. All pictures are representative of three independent experiments
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3.6 | Resveratrol up‐regulates differentiation gene 
expressions
Firstly, to exclude an unsafe effect of the RSV in f‐LSCs, an MTT 
cell viability assay was performed with 10 µM, 20 µM and 50 µM 
of RSV treatment at 24, 48 and 72 hours. The treatment showed no 
cell toxicity up to a concentration of 50µM (Supporting Information 
3, Figure 4A). At 50 µM of RSV treatment, the growth curve of the 
treated f‐LSCs kept a linear trend comparable with the control f‐LSC 
one, except for a weak inflection observed at 72 hours (Figure 6A). 
Therefore, 50 µM of RSV was chosen for the subsequent experi‐
ments: after 72 hours treatment cell cycle and molecular profile 
analyses were performed. The RSV‐treated f‐LSCs showed a lower 
cell population in S‐phase when compared to the untreated f‐
LSCs (Supporting Information 3, Figure 4B) and we quantified an 
8.65 ± 2.17 PI vs a 27.15 ± 6.43 PI respectively for the treated f‐
LSCs and the untreated f‐LSCs (Figure 6B). The qPCR analysis for 
several cell cycle progression regulator genes reflected the cell cycle 
distribution: a faint variation in ccnd1, cdkn1 and bax mRNA expres‐
sion levels was counterbalanced by absence of variation in c‐kit and 
bcl‐2 (Figure 6C). Finally, in the treated f‐LSCs lower levels of inte‐
grin‐β1 and up‐regulation of pax6, ck15 and sox17 were detected 
(Figure 6D). Moreover, we observed an RSV dose‐dependent effect: 
RSV‐induced regulation of the mRNA expression levels was remark‐
able at a higher RSV concentration (50 µM vs 10 µM RSV): that is, 
sox2 and oct4 mRNA levels were up‐regulated, whereas nanog and 
pfn1 were down‐regulated (Supporting Information 3, Figure 4C).
4  | DISCUSSION
Nowadays, much greater knowledge of the molecular mechanism un‐
derlying the regulation of corneal epithelial specific genes is becom‐
ing the major aim in the field of ocular regenerative medicine. It is 
F I G U R E  4   The integrin‐β1, profilin‐1 
and nanog axis: pfn1 silencing drives 
f‐LSCs to the epithelial differentiation. 
A, Immunofluorescence assay for 
integrin‐β1 (CD29) and NANOG in no‐
siRNA f‐LSCs (i‐iii, vii‐ix) and pfn1‐siRNA 
transfected f‐LSCs (iv‐vi, x‐xiii). In green 
and red staining, NANOG and integrin‐β1 
respectively, in blue staining the cell 
nuclei. B, Proliferation assay (MTT) at 
96 h for the control f‐LSCs (dark blue), no‐
siRNA f‐LSCs (black line) and pfn1‐siRNA 
transfected f‐LSCs (green line). C, The bar 
plot represents the comparative cell cycle 
distribution analysis between pfn1‐siRNA 
transfected f‐LSCs and the control f‐LSCs 
(G2M + S = proliferation index (PI)), at 72 h 
silencing. D, qPCR analysis of stromal 
mesenchymal stem cell markers oct4, 
sox2 and nanog (top panel) and early 
epithelial progenitor markers sox17, pax6 
and ΔNp63α (bottom panel) in pfn1‐siRNA 
transfected f‐LSCs vs the control f‐LSCs 
and in pfn1‐siRNA transfected f‐LSCs vs 
LESCs, respectively. The bar graphs were 
performed by GraphPad Software, Inc, 
California and are represented as ± SD 
with **P < 0.02, ***P < 0.001, ns = no 
significant, SD = Standard deviation; P = P 
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known that the differentiation process is closely related to expression 
of the stem triad (sox2/oct4/nanog) and its role during commitment 
processes. Despite the progress in experimental and laboratory pro‐
cedures, all consecutive steps within the process remain unclear and 
it is imperative for scientists to have a detailed picture of the peculiar 
moment when a cell makes the decision to commit itself. In this con‐
text, our research focused on profilin‐1 and its relation with the stem 
transcriptional triad in cell fate determination of f‐LSCs. Previously, we 
proposed a protein stem‐cell profile enriched with several cytoskel‐
eton‐remodelling and wound healing proteins, including profilin‐1. In 
this work, we speculate that different expression levels of profilin‐1 
could affect the equilibrium between stem and epithelial differen‐
tiation‐related genes. Moreover, we show the possibility to modulate 
profilin‐1 levels with RSV treatment and to obtain an epithelial com‐
mitment through down‐regulation of nanog expression. It is known 
that sox2 and oct4 closely collaborate to maintain higher nanog level 
expression to ensure cellular self‐renewal.38 First of all, we indicate a 
hierarchy within the stem triad: our silencing experiments elect nanog 
as the key regulator of stemness for its ability to down‐regulate the 
expression of the f‐LSC stem profile. When a cell chooses differen‐
tiation rather than renewal, a balance of bax/bcl‐2 and cdkn‐1/c‐kit 
slows down the cell cycle 39: our findings highlight this equilibrium in 
nanog‐siRNA transfected f‐LSCs. Moreover, oct4 replaces sox2, its 
natural partner, with sox17; nanog is present at lower protein levels 
and together with all analysed proteins (integrin‐β1, profilin‐1, cofilin‐1, 
lectin‐1, thioredoxin‐1 and hsp90, pax6 and ΔNp63α, bax, ccnd1 and 
cdkn1b) is one of the protagonists of a differentiation network.40‐44 
The f‐LSCs appeared to be a ΔNp63α‐/SOX17‐ and highly integ‐
rin‐β1+/PFN1+/NANOG + cell population. By contrast, when pfn1 is 
knocked down both integrin‐β1 and nanog are reduced and the cells 
show a lower rate of growth in spite of the appearance of epithelial 
related genes, as revealed by cell cycle and proliferation‐related gene 
analyses.45,46 Finally, we investigated the effect of RSV on f‐LSCs. It 
is known that RVS and other polyphenols have beneficial effects on 
several anterior eye cells‐based diseases and promote differentiation 
in vitro culture.47‐50 Our findings show that RSV treatment does not 
affect f‐LSCs viability, whereas it outlines a limbal epithelial progeni‐
tor‐like molecular profile characterised by expression of sox17, pax6, 
ΔNp63α, CK15 and emphasises involvement of profilin‐1, integrin‐β1 
and nanog. Cheng et al proposed a mechanism underlying inhibition 
of gastric cancer progression through profilin‐1 silencing: they demon‐
strated that profilin‐1 silencing inhibits gastric cancer cell proliferation, 
migration and invasion through the integrin‐β1 pathway, with involve‐
ment of mTOR activity.51 We speculate that a similar mechanism could 
occur in f‐LSCs during epithelial differentiation and a working model of 
differentiation process regulation could be developed: as suggested by 
our findings, pfn1 affects intracellular events downstream of integrin‐
β1/mTOR including epithelial gene expression.
In summary, most ocular surface diseases are caused by dysfunc‐
tion of LSCs, which leads to the inability to preserve corneal epithe‐
lial physiology. To the best of our knowledge, this is the first work 
proposing a possible differentiation of f‐LSCs into limbal epithelial 
progenitor‐like cell by resveratrol‐induced profilin‐1‐down‐regula‐
tion. Moreover, the supplying of factors in vivo able to protect and 
activate f‐LCS could be the linchpin to identify a resolving treatment 
of corneal diseases with limbal stem cell dysfunction. Our results sug‐
gest that profilin‐1 and its related functions may be considered excel‐
lent candidates for development of a successful cell‐based therapy to 
resolve ocular damaged supporting regeneration and wound healing.
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F I G U R E  5   Profilin‐1/mTOR crosstalk. 
A, Western blot analysis: on the left image 
are reported the gel bands of P‐m‐TOR, m‐
TOR and NANOG; on the right image the 
histogram graph represents the protein 
quantification as the optical density (OD) 
values. B, The schematic diagram of the 
mechanism underlines the involvement of 
pfn1, integrin‐β1 and mTOR in regulation 
of molecular expression. The stem cell 
gene induction signalling in pfn1 + f‐
LSCs (left image), the down regulation 
of profilin‐1 expression leads f‐LSCs to 
choose a differentiation fate (right image). 
mTOR: Mammalian target of rapamycine; 
P: Phosphate
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